TAS1553
oral RNR subunit interaction inhibitor Ph. I candidate in oncology HTS and SBDD Commun. Biol. Taiho Pharmaceutical Co., Ltd., Tsukuba, JP
Molecules of the Month - June 2022
oral RNR subunit interaction inhibitor Ph. I candidate in oncology HTS and SBDD Commun. Biol. Taiho Pharmaceutical Co., Ltd., Tsukuba, JP
Molecules of the Month - June 2022